ALS (FRA:CP4) Beta: 1.6720 (As of Jun. 26, 2026)


FRA:CP4 ALS Ltd FRA:CP4
87 GF Score
Price €13.90
GF Value €11.25
Valuation Modestly Overvalued
View Full Analysis

What is ALS Beta?

ALS FRA:CP4 +2.96% 87 Beta is 1.6720 as of Jun. 26, 2026. GuruFocus rates FRA:CP4 with a GF Score™ of 87/100 and a GF Value™ of €11.25 (Modestly Overvalued).

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), ALS's Beta is 1.6720.


ALS  (FRA:CP4) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


ALS Beta Related Terms


ALS Beta Historical Data

* Premium members only.

The historical data trend for ALS's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ALS Beta Chart

ALS Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.23 1.01 1.85 1.66 1.69

ALS Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 1.78 1.66 1.54 1.69

FRA:CP4 vs VRSK, EFX, BAH: Beta Comparison

For the Consulting Services subindustry, ALS's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ALS Beta vs Business Services Industry

For the Business Services industry and Industrials sector, ALS's Beta distribution charts can be found below:

* The bar in red indicates where ALS's Beta falls into.


FRA:CP4
87GF Score
ALS Ltd FRA:CP4
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ALS Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.6720 mean?
ALS (FRA:CP4) has a Beta of 1.6720 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for ALS and its competitors.
Is ALS's Beta too high?
ALS's current Beta is 1.6720. Overall, ALS has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ALS's Beta compare to VRSK and EFX?
ALS's Beta of 1.6720 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Business Services company?
A good Beta depends on the Business Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for ALS and its competitors. ALS's current Beta is 1.6720. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALS stock overvalued right now?
Based on GuruFocus' analysis, ALS (FRA:CP4) is currently considered Modestly Overvalued. The stock's GF Value™ is €11.25, compared to a current price of €13.90 — trading 23.6% above its estimated fair value. The current Beta is 1.6720. ALS's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For ALS (FRA:CP4), the current Beta is 1.6720 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ALS (FRA:CP4) Overvalued in 2026?

Based on GuruFocus' analysis, ALS stock appears to be overvalued. The current stock price of €13.90 is trading 23.6% above its estimated GF Value™ of €11.25. GuruFocus considers ALS to be Modestly Overvalued.

Key valuation signals for FRA:CP4:

  • Beta: 1.6720
  • GF Value™: €11.25 vs. price of €13.90 (23.6% above fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the FRA:CP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ALS Business Description

Other Exchanges CPBLF:USAALQ:Australia
Address 25 King Street, Level 9B, Bowen Hills, Brisbane, QLD, AUS, 4006
Founded in the 1880s and listed on the ASX in 1952, ALS operates two divisions: commodities and life sciences. ALS commodities traditionally generated the majority of underlying earnings, providing geochemistry, metallurgy, inspection, and mine site services for the global mining industry. Expansion into environmental, pharmaceutical, and food testing areas has lessened earnings exposure to commodities.
87GF Score

Get the complete analysis for FRA:CP4

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.90
Price
€11.25
GF Value